{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:08:17Z","timestamp":1791259697079,"version":"4.1.0"},"reference-count":58,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Inactivation of the tumor suppressor gene, CDKN2A, can occur by deletion, methylation, or mutation. We assessed the principal mode of inactivation in childhood acute lymphoblastic leukemia (ALL) and frequency in biologically relevant subgroups. Mutation or methylation was rare, whereas genomic deletion occurred in 21% of B-cell precursor ALL and 50% of T-ALL patients. Single nucleotide polymorphism arrays revealed copy number neutral (CNN) loss of heterozygosity (LOH) in 8% of patients. Array-based comparative genomic hybridization demonstrated that the mean size of deletions was 14.8 Mb and biallelic deletions composed a large and small deletion (mean sizes, 23.3 Mb and 1.4 Mb). Among 86 patients, only 2 small deletions were below the resolution of detection by fluorescence in situ hybridization. Patients with high hyperdiploidy, ETV6-RUNX1, or 11q23\/MLL rearrangements had low rates of deletion (11%, 15%, 13%), whereas patients with t(9;22), t(1;19), TLX3, or TLX1 rearrangements had higher frequencies (61%, 42%, 78%, and 89%). In conclusion, CDKN2A deletion is a significant secondary abnormality in childhood ALL strongly correlated with phenotype and genotype. The variation in the incidence of CDKN2A deletions by cytogenetic subgroup may explain its inconsistent association with outcome. CNN LOH without apparent CDKN2A inactivation suggests the presence of other relevant genes in this region.<\/jats:p>","DOI":"10.1182\/blood-2008-07-166801","type":"journal-article","created":{"date-parts":[[2008,10,6]],"date-time":"2008-10-06T20:54:06Z","timestamp":1223326446000},"page":"100-107","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":165,"title":["A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups"],"prefix":"10.1182","volume":"113","author":[{"given":"Sarina","family":"Sulong","sequence":"first","affiliation":[{"name":"Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony V.","family":"Moorman","sequence":"additional","affiliation":[{"name":"Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne;"},{"name":"Leukaemia Research Cytogenetics Group and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A. E.","family":"Irving","sequence":"additional","affiliation":[{"name":"Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C.","family":"Strefford","sequence":"additional","affiliation":[{"name":"Leukaemia Research Cytogenetics Group and"},{"name":"Cancer Genomics Group, Cancer Sciences Division, University of Southampton, Southampton;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe J.","family":"Konn","sequence":"additional","affiliation":[{"name":"Leukaemia Research Cytogenetics Group and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian C.","family":"Case","sequence":"additional","affiliation":[{"name":"Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Minto","sequence":"additional","affiliation":[{"name":"Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry E.","family":"Barber","sequence":"additional","affiliation":[{"name":"Leukaemia Research Cytogenetics Group and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Parker","sequence":"additional","affiliation":[{"name":"Leukaemia Research Cytogenetics Group and"},{"name":"Cancer Genomics Group, Cancer Sciences Division, University of Southampton, Southampton;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Wright","sequence":"additional","affiliation":[{"name":"Leukaemia Research Cytogenetics Group and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam R. M.","family":"Stewart","sequence":"additional","affiliation":[{"name":"Leukaemia Research Cytogenetics Group and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Bailey","sequence":"additional","affiliation":[{"name":"Royal Victoria Infirmary, Newcastle upon Tyne; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick P.","family":"Bown","sequence":"additional","affiliation":[{"name":"National Health Service (NHS) Northern Genetics Service, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Hall","sequence":"additional","affiliation":[{"name":"Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine J.","family":"Harrison","sequence":"additional","affiliation":[{"name":"Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne;"},{"name":"Leukaemia Research Cytogenetics Group and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111714555377100_B1","first-page":"F115","article-title":"The p16(INK4a)\/CDKN2A tumor suppressor and its relatives.","volume":"1378","author":"Ruas","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"2019111714555377100_B2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1634\/theoncologist.7-1-73","article-title":"Molecular aspects of the mammalian cell cycle and cancer.","volume":"7","author":"Sandal","year":"2002","journal-title":"Oncologist"},{"key":"2019111714555377100_B3","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.leu.2401043","article-title":"Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.","volume":"12","author":"Drexler","year":"1998","journal-title":"Leukemia"},{"key":"2019111714555377100_B4","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1038\/sj.onc.1205322","article-title":"Tumor suppressor genes in normal and malignant hematopoiesis.","volume":"21","author":"Krug","year":"2002","journal-title":"Oncogene"},{"key":"2019111714555377100_B5","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0145-2126(97)00075-1","article-title":"Allelic loss in childhood acute lymphoblastic leukemia.","volume":"21","author":"Baccichet","year":"1997","journal-title":"Leukemia Res"},{"key":"2019111714555377100_B6","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/sj.leu.2400817","article-title":"Homozygous deletions at 9p21 in childhood acute lymphoblastic leukemia detected by microsatellite analysis.","volume":"11","author":"Takeuchi","year":"1997","journal-title":"Leukemia"},{"key":"2019111714555377100_B7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/sj.leu.2402727","article-title":"Long-term study of the clinical significance of loss of heterozygosity in childhood acute lymphoblastic leukemia.","volume":"17","author":"Takeuchi","year":"2003","journal-title":"Leukemia"},{"key":"2019111714555377100_B8","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1158\/0008-5472.CAN-04-2604","article-title":"Loss of heterozygosity in childhood acute lymphoblastic leukemia detected by genome-wide microarray single nucleotide polymorphism analysis.","volume":"65","author":"Irving","year":"2005","journal-title":"Cancer Res"},{"key":"2019111714555377100_B9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.neo.7900033","article-title":"p27KIP1 deletions in childhood acute lymphoblastic leukemia.","volume":"1","author":"Komuro","year":"1999","journal-title":"Neoplasia"},{"key":"2019111714555377100_B10","doi-asserted-by":"crossref","first-page":"11563","DOI":"10.1073\/pnas.201167798","article-title":"Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression.","volume":"98","author":"Kwabi-Addo","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111714555377100_B11","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1158\/1078-0432.CCR-05-0411","article-title":"Comprehensive analysis of CDKN2A status in microdissected urothelial cell carcinoma reveals potential haploinsufficiency, a high frequency of homozygous co-deletion and associations with clinical phenotype.","volume":"11","author":"Chapman","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2019111714555377100_B12","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1182\/blood.V86.4.1269.bloodjournal8641269","article-title":"Homozygous deletions of p16\/MTS1 gene are frequent but mutations are infrequent in childhood T-cell acute lymphoblastic leukemia.","volume":"86","author":"Ohnishi","year":"1995","journal-title":"Blood"},{"key":"2019111714555377100_B13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/gcc.10188","article-title":"CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia.","volume":"37","author":"Bertin","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"2019111714555377100_B14","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1038\/sj.onc.1201428","article-title":"Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia.","volume":"15","author":"Iravani","year":"1997","journal-title":"Oncogene"},{"key":"2019111714555377100_B15","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1182\/blood.V95.6.1942","article-title":"Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications.","volume":"95","author":"Wong","year":"2000","journal-title":"Blood"},{"key":"2019111714555377100_B16","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/sj.leu.2403060","article-title":"Concurrent methylation of multiple genes in childhood ALL: correlation with phenotype and molecular subgroup.","volume":"17","author":"Gutierrez","year":"2003","journal-title":"Leukemia"},{"key":"2019111714555377100_B17","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s00277-003-0744-8","article-title":"Epigenetic inactivation of INK4\/CDK\/RB cell cycle pathway in acute leukemias.","volume":"82","author":"Chim","year":"2003","journal-title":"Ann Hematol"},{"key":"2019111714555377100_B18","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1182\/blood-2004-03-0954","article-title":"Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia.","volume":"104","author":"Roman-Gomez","year":"2004","journal-title":"Blood"},{"key":"2019111714555377100_B19","first-page":"97","article-title":"Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemia.","volume":"12","author":"Matsushita","year":"2004","journal-title":"Oncol Rep"},{"key":"2019111714555377100_B20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1590\/S1516-31802003000200005","article-title":"Analysis of p16 gene mutations and deletions in childhood acute lymphoblastic leukemias.","volume":"121","author":"Lemos","year":"2003","journal-title":"Sao Paulo Med J"},{"key":"2019111714555377100_B21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0145-2126(98)00146-5","article-title":"Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.","volume":"23","author":"Kawamura","year":"1999","journal-title":"Leukemia Res"},{"key":"2019111714555377100_B22","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1182\/blood.V86.2.755.bloodjournal862755","article-title":"Analysis of a family of cyclin-dependent kinase inhibitors: p15\/MTS2\/INK4B, p16\/MTS1\/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood.","volume":"86","author":"Takeuchi","year":"1995","journal-title":"Blood"},{"key":"2019111714555377100_B23","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1182\/blood.V85.12.3431.bloodjournal85123431","article-title":"p15ink4B and p16ink4 gene inactivation in acute lymphocytic leukemia.","volume":"85","author":"Rasool","year":"1995","journal-title":"Blood"},{"key":"2019111714555377100_B24","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1182\/blood.V85.3.657.bloodjournal853657","article-title":"p16 gene homozygous deletions in acute lymphoblastic leukemia.","volume":"85","author":"Quesnel","year":"1995","journal-title":"Blood"},{"key":"2019111714555377100_B25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2141.2001.02643.x","article-title":"The Leukaemia Research Fund\/United Kingdom Cancer Cytogenetics Group karyotype database in acute lymphoblastic leukaemia: a valuable resource for patient management.","volume":"113","author":"Harrison","year":"2001","journal-title":"Br J Haematol"},{"key":"2019111714555377100_B26","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.8153634","article-title":"A cell cycle regulator potentially involved in genesis of many tumor types.","volume":"264","author":"Kamb","year":"1994","journal-title":"Science"},{"key":"2019111714555377100_B27","doi-asserted-by":"crossref","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","article-title":"Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.","volume":"93","author":"Herman","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111714555377100_B28","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1158\/0008-5472.CAN-05-0465","article-title":"A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays.","volume":"65","author":"Nannya","year":"2005","journal-title":"Cancer Res"},{"key":"2019111714555377100_B29","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1073\/pnas.0602360103","article-title":"Complex genomic alterations and gene expression in acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.","volume":"103","author":"Strefford","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111714555377100_B30","doi-asserted-by":"crossref","first-page":"17765","DOI":"10.1073\/pnas.0407979101","article-title":"Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA.","volume":"101","author":"Barrett","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111714555377100_B31","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1038\/sj.onc.1210190","article-title":"Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization.","volume":"26","author":"Strefford","year":"2007","journal-title":"Oncogene"},{"key":"2019111714555377100_B32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/sj.leu.2404994","article-title":"Disruption of ETV6 in intron 2 results in upregulatory and insertional events in childhood acute lymphoblastic leukaemia.","volume":"22","author":"Jalali","year":"2007","journal-title":"Leukemia"},{"key":"2019111714555377100_B33","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1182\/blood-2006-08-041012","article-title":"Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL).","volume":"109","author":"Akasaka","year":"2007","journal-title":"Blood"},{"key":"2019111714555377100_B34","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1089\/dna.2004.23.777","article-title":"Molecular analysis of GISTs: evaluation of sequencing and dHPLC.","volume":"23","author":"Metaxa-Mariatou","year":"2004","journal-title":"DNA Cell Biol"},{"key":"2019111714555377100_B35","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/jnci\/91.18.1569","article-title":"Biologic and biochemical analyses of p16(INK4a) mutations from primary tumors.","volume":"91","author":"Yarbrough","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"2019111714555377100_B36","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ijc.10919","article-title":"Clinical course of bladder neoplasms and single nucleotide polymorphisms in the CDKN2A gene.","volume":"104","author":"Sakano","year":"2003","journal-title":"Int J Cancer"},{"key":"2019111714555377100_B37","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1200\/JCO.2003.08.101","article-title":"High prognostic value of p16INK4 alterations in gastrointestinal stromal tumors.","volume":"21","author":"Schneider-Stock","year":"2003","journal-title":"J Clin Oncol"},{"key":"2019111714555377100_B38","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00277-005-0041-9","article-title":"Methylation of the INK4A\/ARF locus in blood mononuclear cells.","volume":"85","author":"Deligezer","year":"2006","journal-title":"Ann Hematol"},{"key":"2019111714555377100_B39","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature"},{"key":"2019111714555377100_B40","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.leukres.2008.01.014","article-title":"CDKN2A deletions in acute lymphoblastic leukemia of adolescents and young adults: an array CGH study.","volume":"32","author":"Usvasalo","year":"2008","journal-title":"Leukemia Res"},{"key":"2019111714555377100_B41","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1182\/blood-2007-05-088310","article-title":"Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray.","volume":"111","author":"Kawamata","year":"2008","journal-title":"Blood"},{"key":"2019111714555377100_B42","first-page":"881","article-title":"The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B-lineage acute lymphoblastic leukemia of childhood: results of the EORTC studies 58881 and 58951.","volume":"91","author":"Mirebeau","year":"2006","journal-title":"Haematologica"},{"key":"2019111714555377100_B43","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1182\/blood-2007-07-092015","article-title":"t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL).","volume":"111","author":"Russell","year":"2008","journal-title":"Blood"},{"key":"2019111714555377100_B44","doi-asserted-by":"crossref","first-page":"8597","DOI":"10.1158\/0008-5472.CAN-05-0842","article-title":"Genomewide single nucleotide polymorphism microarray mapping in basal cell carcinomas unveils uniparental disomy as a key somatic event.","volume":"65","author":"Teh","year":"2005","journal-title":"Cancer Res"},{"key":"2019111714555377100_B45","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1158\/0008-5472.CAN-04-3247","article-title":"Genome-wide association study in esophageal cancer using GeneChip mapping 10K array.","volume":"65","author":"Hu","year":"2005","journal-title":"Cancer Res"},{"key":"2019111714555377100_B46","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1158\/0008-5472.375.65.2","article-title":"Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias.","volume":"65","author":"Raghavan","year":"2005","journal-title":"Cancer Res"},{"key":"2019111714555377100_B47","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"2019111714555377100_B48","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1158\/0008-5472.CAN-05-2017","article-title":"Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias.","volume":"65","author":"Fitzgibbon","year":"2005","journal-title":"Cancer Res"},{"key":"2019111714555377100_B49","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1182\/blood-2003-04-1128","article-title":"Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia.","volume":"102","author":"Moorman","year":"2003","journal-title":"Blood"},{"key":"2019111714555377100_B50","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood.V97.2.572","article-title":"Hemizygous p16(INK4A) deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse.","volume":"97","author":"Carter","year":"2001","journal-title":"Blood"},{"key":"2019111714555377100_B51","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1046\/j.1365-2141.2001.02586.x","article-title":"In vitro drug resistance and prognostic impact of p16INK4A\/P15INK4B deletions in childhood T-cell acute lymphoblastic leukaemia.","volume":"112","author":"Ramakers-van Woerden","year":"2001","journal-title":"Br J Haematol"},{"key":"2019111714555377100_B52","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1182\/blood.V99.7.2620","article-title":"p16INK4a immunocytochemical analysis is an independent prognostic factor in childhood acute lymphoblastic leukemia.","volume":"99","author":"Dalle","year":"2002","journal-title":"Blood"},{"key":"2019111714555377100_B53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/08880019709030900","article-title":"Incidence and clinical significance of CDKN2\/MTS1\/P16ink4A and MTS2\/P15ink4B gene deletions in childhood acute lymphoblastic leukemia.","volume":"14","author":"Zhou","year":"1997","journal-title":"Pediatr Hematol Oncol"},{"key":"2019111714555377100_B54","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1182\/blood.V85.10.2685.bloodjournal85102685","article-title":"Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features.","volume":"85","author":"Fizzotti","year":"1995","journal-title":"Blood"},{"key":"2019111714555377100_B55","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.leu.2403769","article-title":"CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia.","volume":"19","author":"van Zutven","year":"2005","journal-title":"Leukemia"},{"key":"2019111714555377100_B56","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1182\/blood.V99.12.4629","article-title":"Deletion analysis of p16INKa and p15INKb in relapsed childhood acute lymphoblastic leukemia.","volume":"99","author":"Graf Einsiedel","year":"2002","journal-title":"Blood"},{"key":"2019111714555377100_B57","first-page":"1537","article-title":"Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group.","volume":"94","author":"Heerema","year":"1999","journal-title":"Blood"},{"key":"2019111714555377100_B58","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1365-2141.2001.02668.x","article-title":"Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol.","volume":"113","author":"Hann","year":"2001","journal-title":"Br J Haematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/113\/1\/100\/1302681\/zh800109000100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/113\/1\/100\/1302681\/zh800109000100.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T04:01:02Z","timestamp":1684555262000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/113\/1\/100\/24378\/A-comprehensive-analysis-of-the-CDKN2A-gene-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2008-07-166801","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1139008.596112","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,1]]}}}